Simpson Thacher Expands Secondaries Team With Hire of Ed Ford and Sacha Gofton-Salmond
Simpson Thacher & Bartlett LLP announced today that Ed Ford and Sacha Gofton-Salmond will join the Firm as Partners in the London office, where they will focus on secondaries transactions.
“Ed and Sacha are highly regarded in the secondaries space, having built up a market leading practice in recent years and will add depth to our renowned Private Funds and Fund Transactions Practices, further bolstering our ability to advise sponsors and investors on liquidity solutions that provide additional flexibility to address an ever-changing market,” said Alden Millard, Chair of Simpson Thacher’s Executive Committee. “We are thrilled to welcome them to Simpson Thacher.”
“Simpson Thacher has developed a robust presence in the fund transactional space, which was strengthened by the addition of Lauren King in New York in 2021,” said Michael Wolitzer, Head of Simpson Thacher’s Investment Funds Practice. “With the addition of Ed and Sacha, the Firm is further augmenting its capabilities to provide sponsor clients and other industry participants with multidisciplinary secondaries solutions around the globe.”
Ed and Sacha both specialize in advising clients on the structuring and negotiation of highly complex secondary market solutions, ranging from GP- and LP-led secondary transactions to NAV financings, preferred equity financings and other structured secondary transactions. Both lawyers join the Firm from Travers Smith.
“Ed and Sacha are both incredibly talented lawyers that have the versatile experience and commercial creativity that is the hallmark of Simpson Thacher’s Investment Funds Practice,” said Jason Glover, Head of Simpson Thacher’s London office and the Firm’s European Funds team. “We have admired Ed’s and Sacha’s respective success in the secondaries space for some time and believe that their arrival at Simpson Thacher will enhance our existing secondaries transaction platform in London. Such hires mark the latest step in enhancing our private funds offering and solidifying our position as the global investment funds law firm of choice.”
Simpson Thacher’s Fund Transactions Practice advises on the full breadth of secondaries transactions, as well as complex control and minority-stakes transactions involving alternative asset managers and preferred and structured financings for funds, their management companies and other industry participants. Drawing upon the Firm’s more than 40 years of experience in the private equity industry, the global team comprises funds, mergers and acquisitions, finance, tax and other lawyers who provide commercially-driven, comprehensive transactional advice for the world’s most sophisticated sponsors. The multidisciplinary team offers deep market knowledge and creative, tailored advice on transactions, including traditional and synthetic secondaries deals, GP-led restructurings, preferred equity transactions and other liquidity solutions.
ABOUT SIMPSON THACHER
Simpson Thacher & Bartlett LLP (www.simpsonthacher.com) is one of the world’s leading international law firms. The Firm was established in 1884 and has more than 1,000 lawyers. Headquartered in New York with offices in Beijing, Brussels, Hong Kong, Houston, London, Los Angeles, Palo Alto, São Paulo, Tokyo and Washington, D.C., the Firm provides coordinated legal advice and transactional capability to clients around the globe.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230213005393/en/
Contact information
Arielle Katz
Communications Manager
mediainquiries@stblaw.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Owkin's Specialized Biological AI Agent Pathology Explorer Launches with Anthropic's Claude for Healthcare and Life Sciences12.1.2026 19:00:00 EET | Press release
Owkin, an AI company on a mission to solve the complexity of biology, today announced that its interoperable Pathology Explorer AI agent will be included in the launch of Claude for Healthcare and Life Sciences (HCLS) by Anthropic. This marks the first time a highly specialized, world-leading biological agent trained primarily on multimodal patient data is accessible through the Model Context Protocol (MCP) to a broad audience of healthcare and life sciences professionals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112836381/en/ Owkin's Specialized Biological AI Agent Pathology Explorer Launches with Anthropic's Claude for Healthcare and Life Sciences. The collaboration enables seamless integration of Owkin's advanced pathology analysis capabilities into Claude's AI platform, making sophisticated biological intelligence accessible to healthcare organizations, pharmaceutical companies, and research institutions within
Owkin Brings Biology Super Intelligence Closer to Reality with New AI Infrastructure for Biological Breakthroughs12.1.2026 19:00:00 EET | Press release
Owkin, the AI company on a mission to solve the complexity of biology, today announced the launch of its agentic infrastructure for biology, making its best-in-class AI agents available to the healthcare ecosystem. The announcement comes at the JPM Healthcare Conference 2026 and follows Owkin’s recent strategic partnerships and its just-announced integration with Claude for Healthcare and Life Sciences by Anthropic. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112461277/en/ Owkin, a 10-year-old AI company with $300 million in funding, is introducing the infrastructure, built on a unique advantage: unparalleled, curated, multimodal patient data from diverse geographies, collected from more than 800 hospitals over a decade. While other companies focus primarily on data derived from laboratory research, Owkin's patient data-trained AI agents enable comprehensive and clinically relevant insights that more accurately reflect
Berkshire Hathaway Specialty Insurance Names David Lee Global Chief Human Resources Officer12.1.2026 17:27:00 EET | Press release
Berkshire Hathaway Specialty Insurance (BHSI) today announced the promotion of David Lee to Global Chief Human Resources Officer. “I am thrilled to have David leading our human resources group worldwide,” said Peter Eastwood, President and Chief Executive Officer, BHSI. “An experienced HR practitioner and lifelong student of the profession, his deep expertise, stellar work ethic, and commitment to BHSI values will continue to drive success across our global talent and HR initiatives.” David succeeds Kim Briones, who has led BHSI’s HR group since the company’s founding in 2013 and is retiring from her full-time role. “I want to express my sincere gratitude to Kim for her partnership and friendship over many years and for her outstanding leadership in building our HR function from the ground up,” Peter added. “She has played a pivotal role in growing and developing our company’s greatest asset – our global team of individuals with excellent capabilities and strong character – and in help
Owkin Advances Frontier Model Development for Biological Artificial Super Intelligence, Accelerated by NVIDIA12.1.2026 17:00:00 EET | Press release
Owkin, an AI company on a mission to solve the complexity of biology, today announced a collaboration with NVIDIA to enhance OwkinZero, Owkin's biological large reasoning model. The collaboration will leverage NVIDIA's advanced AI computing ecosystem, including the Nemotron family of open models and the NVIDIA NeMo framework to improve the performance, scalability, guardrails, and robustness of Owkin's biological reasoning capabilities to accelerate future breakthroughs in drug discovery and development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112573701/en/ Owkin Advances Frontier Model Development for Biological Artificial Super Intelligence, Accelerated by NVIDIA. This marks Owkin's first collaboration with NVIDIA and represents a significant milestone in building the agentic infrastructure necessary for achieving Biological Artificial Super Intelligence (BASI). The work brings together Owkin's expertise in biolo
SecurityBridge Announces CEO Transition to Accelerate Global Expansion12.1.2026 16:15:00 EET | Press release
SecurityBridge, a leading provider of cybersecurity solutions for SAP, today announced the appointment of Jesper Zerlang as Chief Executive Officer, effective January 1, 2026. Zerlang transitions from his role as Chairman of the Board, a position he has held for the past 12 months, as the company enters its next phase of international expansion, backed by funds advised by BUBregal Unternehmerkapital (BU). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112824449/en/ Jesper Zerlang appointed Chief Executive Officer, SecurityBridge SecurityBridge protects SAP environments for large enterprises by reducing cyber risk across mission-critical SAP landscapes. The company is trusted by global customers to safeguard systems that power core operations, financial processes, supply chains, and digital transformation programs. “SecurityBridge is uniquely positioned at the intersection of cybersecurity and SAP – a domain I know deeply
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
